South Africa Oligonucleotide Cdmo Market Size & Outlook
Related Markets
South Africa oligonucleotide cdmo market highlights
- The South Africa oligonucleotide cdmo market generated a revenue of USD 10.3 million in 2024 and is expected to reach USD 27.1 million by 2033.
- The South Africa market is expected to grow at a CAGR of 11.4% from 2025 to 2033.
- In terms of segment, contract manufacturing was the largest revenue generating service in 2024.
- Contract Development is the most lucrative service segment registering the fastest growth during the forecast period.
Oligonucleotide cdmo market data book summary
| Market revenue in 2024 | USD 10.3 million |
| Market revenue in 2033 | USD 27.1 million |
| Growth rate | 11.4% (CAGR from 2025 to 2033) |
| Largest segment | Contract manufacturing |
| Fastest growing segment | Contract Development |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Contract Manufacturing, Contract Development |
Other key industry trends
- In terms of revenue, South Africa accounted for 1.1% of the global oligonucleotide cdmo market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa oligonucleotide cdmo market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 7.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide CDMO Market Scope
Oligonucleotide CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| STA Pharmaceutical | View profile | 5001-10000 | Shanghai, Shanghai, China, Asia | https://www.stapharma.com |
| Bachem | View profile | 501-1000 | Bubendorf, Basel-Landschaft, Switzerland, Europe | https://www.bachem.com/ |
| Curia Global, Inc. | View profile | - | - | - |
| Aurigene Pharmaceutical Services Ltd. | View profile | - | - | - |
| Creative Peptides | View profile | 1-10 | New York, New York, United States, North America | http://www.creative-peptides.com/index.html |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| SYLENTIS | View profile | 11-50 | Madrid, Madrid, Spain, Europe | http://www.sylentis.com |
| Euroapi SA | View profile | 3326 | 15 rue Traversiere, Paris, France, 75012 | https://www.euroapi.com |
| PolyPeptide Group AG | View profile | 1273 | Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 | https://www.polypeptide.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
South Africa oligonucleotide cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide cdmo market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 70.87% in 2024. Horizon Databook has segmented the South Africa oligonucleotide cdmo market based on contract manufacturing, contract development covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to South Africa oligonucleotide cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa oligonucleotide cdmo market databook
-
Our clientele includes a mix of oligonucleotide cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa oligonucleotide cdmo market , including forecasts for subscribers. This country databook contains high-level insights into South Africa oligonucleotide cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa oligonucleotide cdmo market size, by service, 2021-2033 (US$M)
South Africa Oligonucleotide CDMO Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
